# The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors

> **NCT05124951** · PHASE2 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Intracranial Germ Cell CNS Tumor, Childhood

## Interventions

- **RADIATION:** Whole-ventricle irradiation
- **DRUG:** Carboplatin/etoposide
- **DRUG:** Ifosfamide/cisplatin/etoposide
- **PROCEDURE:** Second-look surgery

## Key facts

- **NCT ID:** NCT05124951
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-15
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05124951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05124951, "The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05124951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*